Graham Capital Management’s NeoGenomics NEO Stock Holding History

Graham Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,676	Closed	-$391K	–	1415
2026 Q1	$391K	Buy	+52,676	New	+$554K	0.01%	711
2025 Q2	–	Sell	-26,147	Closed	-$248K	–	1502
2025 Q1	$248K	Sell	26,147 -36,522	-58%	-$456K	﹤0.01%	1061
2024 Q4	$1.03M	Buy	62,669 +51,626	+467%	+$802K	0.02%	494
2024 Q3	$163K	Buy	+11,043	New	+$173K	﹤0.01%	956
2024 Q2	–	Sell	-45,460	Closed	-$715K	–	1260
2024 Q1	$715K	Buy	+45,460	New	+$702K	0.01%	523
2023 Q4	–	Sell	-38,757	Closed	-$477K	–	1217
2023 Q3	$477K	Sell	38,757 -19,104	-33%	-$284K	0.01%	577
2023 Q2	$930K	Sell	57,861 -79,320	-58%	-$1.31M	0.03%	385
2023 Q1	$2.39M	Buy	+137,181	New	+$1.95M	0.07%	200
2022 Q3	–	Sell	-153,265	Closed	-$1.25M	–	1222
2022 Q2	$1.25M	Buy	153,265 +118,281	+338%	+$1.13M	0.05%	361
2022 Q1	$425K	Buy	+34,984	New	+$736K	0.01%	605

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Graham Capital Management's NEO Position: Q2 2026 in Review

Graham Capital Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 52,676 shares — an estimated $391K sold.

Graham Capital Management first reported a position in NEO in Q1 2022 and held it in 10 quarters. The position peaked at $2.39M in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Graham Capital Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
Graham Capital Management sold 52,676 NeoGenomics shares in Q2 2026, an estimated $391K.
Graham Capital Management first reported a position in NeoGenomics in Q1 2022 and held it in 10 quarters.
Graham Capital Management's NeoGenomics position peaked at $2.39M in Q1 2023.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.